e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Animal and
ex vivo
models of airway inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Transgenic expression of human glutathione peroxidase-1 prevents cigarette smoke-induced inflammation and emphysema formation in mice
J. D‘Armiento, J. Thankachen, O. Mirochnitchenko, Y. S. Ho, R. Foronjy (New York, NY, New Brunswick, NJ, Detroit, MI, United States Of America)
Source:
Annual Congress 2007 - Animal and
ex vivo
models of airway inflammation
Session:
Animal and
ex vivo
models of airway inflammation
Session type:
Thematic Poster Session
Number:
887
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. D‘Armiento, J. Thankachen, O. Mirochnitchenko, Y. S. Ho, R. Foronjy (New York, NY, New Brunswick, NJ, Detroit, MI, United States Of America). Transgenic expression of human glutathione peroxidase-1 prevents cigarette smoke-induced inflammation and emphysema formation in mice. Eur Respir J 2007; 30: Suppl. 51, 887
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Glutathione peroxidase-1 differentially controls susceptibility to LPS and cigarette smoke-induced lung inflammation
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008
Caspase-7 knockout mice are not protected against cigarette smoke-induced inflammation
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Ablation of ADAM17 protects against cigarette smoke-induced emphysema in mice
Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms
Year: 2019
Targeting NADPH oxidase-2 reduces cigarette smoke-induced lung inflammation and skeletal muscle wasting in mice
Source: International Congress 2018 – Novel drug targets for asthma and COPD
Year: 2018
Disruption of pulmonary lipid homeostasis drives cigarette smoke-induced lung inflammation in mice
Source: Eur Respir J 2015; 46: 1451-1460
Year: 2015
Deficiency in neutrophil serine proteases protects mice from the development of cigarette smoke-induced emphysema
Source: Annual Congress 2010 - Proteases and the matrix
Year: 2010
Oral presentation: SOD3 protects cigarette smoke-induced emphysema associated with reduction of extracellular matrix fragmentation in mice
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010
Inhibition of NOX2 oxidase activity ameliorates cigarette smoke-induced lung inflammation and wasting in mice
Source: International Congress 2016 – Novel insights into the treatment of COPD
Year: 2016
Attenuation of lung inflammation and emphysema induced by cigarette smoke exposure in CXCR3 knockout mice
Source: Annual Congress 2008 - Cell biology of asthma and COPD
Year: 2008
Mitochondria-targeted H2S suppresses and reverses cigarette smoke-induced inflammasome activity and lung injury in experimental COPD
Source: ERS Lung Science Conference 2020
Year: 2020
RAGE and cigarette smoke-induced pulmonary lesions: a chronic study on genetically manipulated mice
Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Year: 2009
Cigarette smoke-induced lung inflammation is skewed in estrogen receptor-alpha deficient mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Increased susceptibility to gammaherpesvirus-induced lung fibrosis of transgenic mice with conditional overexpression of the ER-stress-factor Chop in alveolar epithelium
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019
Overexpression of peroxiredoxin 6 protect mice from ovalbumin-induced airway inflammation and hypersecretion of MUC5AC by reducing ROS levels
Source: Annual Congress 2011 - Animal models of airway inflammation
Year: 2011
Role of ß2-adrenergic receptor in cigarette smoke-induced COPD in mice
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
Effects of thioredoxin-1 on accelerated emphysema progression in cigarette smoke-exposed mice challenged with polyinosine-polycytidylic acid
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
LATE-BREAKING ABSTRACT: BRP-39 contribute to cigarette smoke-induced inflammation and emphysema in mice and humans
Source: Annual Congress 2009 - Airway cell biology
Year: 2009
Cigarette smoke results in accelerated airspace enlargement in Smad3 KO mice through increased alveolar cell apoptosis
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
Enhanced neutrophilic inflammation in IL-10-deficient mice exposed to cigarette smoke via TNF-α regulation
Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Year: 2012
LPS accelerates cigarette smoke-induced deterioration in respiratory function and airway inflammation in mice
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept